Chao-Yun Cai

发表

Sitravatinib, a Tyrosine Kinase Inhibitor, Inhibits the Transport Function of ABCG2 and Restores Sensitivity to Chemotherapy-Resistant Cancer Cells in vitro

S. Ambudkar, Zhe-Sheng Chen, Zhuoxun Wu, 2020, Frontiers in Oncology.

Overexpression of ABCB1 Transporter Confers Resistance to mTOR Inhibitor WYE-354 in Cancer Cells

Zhe-Sheng Chen, Dong-Hua Yang, Zhuoxun Wu, 2020, International journal of molecular sciences.

Hsa-miR-3178/RhoB/PI3K/Akt, a novel signaling pathway regulates ABC transporters to reverse gemcitabine resistance in pancreatic cancer

Jiali Yang, Huaizhi Wang, Chao-Yun Cai, 2022, Molecular cancer.

Derivative of 5-cyano-6-phenylpyrimidin antagonizes ABCB1- and ABCG2-mediated multidrug resistance.

Zhe-Sheng Chen, N. Ji, Liying Ma, 2019, European journal of pharmacology.

Design and synthesis of novel xanthone-triazole derivatives as potential antidiabetic agents: α-Glucosidase inhibition and glucose uptake promotion.

Chao-Yun Cai, Tianyun Lan, G. Ye, 2019, European journal of medicinal chemistry.

Y6, an Epigallocatechin Gallate Derivative, Reverses ABCG2-Mediated Mitoxantrone Resistance

Y. Wen, Zhe-Sheng Chen, Dong-Hua Yang, 2019, Front. Pharmacol..

Xanthone Sulfonamide Derivatives-A Novel Series of α-Glucosidase Inhibitors with Different Inhibitory Types

Yong Rao, Zhisen Huang, Chao-Yun Cai, 2022, Journal of Molecular Structure.

Analogues of xanthones--Chalcones and bis-chalcones as α-glucosidase inhibitors and anti-diabetes candidates.

Yong Rao, Zhishu Huang, Jing Cao, 2017, European journal of medicinal chemistry.

Synthesis of 3-acyloxyxanthone derivatives as α-glucosidase inhibitors: A further insight into the 3-substituents' effect.

Yan Liu, Bo-Chi Wang, Lin Ma, 2016, Bioorganic & medicinal chemistry.

Tetrandrine Interaction with ABCB1 Reverses Multidrug Resistance in Cancer Cells Through Competition with Anti-Cancer Drugs Followed by Downregulation of ABCB1 Expression

Zhe-Sheng Chen, Dong-Hua Yang, Jing-Quan Wang, 2019, Molecules.

Reversal Effect of ALK Inhibitor NVP-TAE684 on ABCG2-Overexpressing Cancer Cells

Zhe-Sheng Chen, Dong-Hua Yang, Zhuoxun Wu, 2020, Frontiers in Oncology.

VKNG-1 Antagonizes ABCG2-Mediated Multidrug Resistance via p-AKT and Bcl-2 Pathway in Colon Cancer: In Vitro and In Vivo Study

Zhe-Sheng Chen, Jing-Quan Wang, Nehaben A. Gujarati, 2021, Cancers.

Multidrug resistance proteins (MRPs): Structure, function and the overcoming of cancer multidrug resistance.

Y. Assaraf, Zhe-Sheng Chen, Jing-Quan Wang, 2021, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.

Dacomitinib antagonizes multidrug resistance (MDR) in cancer cells by inhibiting the efflux activity of ABCB1 and ABCG2 transporters.

Zhe-Sheng Chen, Dong-Hua Yang, Pranav Gupta, 2018, Cancer letters.

Biological evaluation of non-basic chalcone CYB-2 as a dual ABCG2/ABCB1 inhibitor.

Zhe-Sheng Chen, Cai-Ping Tan, Bo Wang, 2020, Biochemical pharmacology.

Olmutinib (BI1482694/HM61713), a Novel Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor, Reverses ABCG2-Mediated Multidrug Resistance in Cancer Cells

Zhe-Sheng Chen, Pranav Gupta, Leli Zeng, 2018, Front. Pharmacol..

Midostaurin Reverses ABCB1-Mediated Multidrug Resistance, an in vitro Study

Zhe-Sheng Chen, Dong-Hua Yang, Dexin Kong, 2019, Front. Oncol..

VS-4718 Antagonizes Multidrug Resistance in ABCB1- and ABCG2-Overexpressing Cancer Cells by Inhibiting the Efflux Function of ABC Transporters

Zhe-Sheng Chen, Dong-Hua Yang, Dexin Kong, 2018, Front. Pharmacol..

Overexpression of ABCB1 Associated With the Resistance to the KRAS-G12C Specific Inhibitor ARS-1620 in Cancer Cells

Zhe-Sheng Chen, Dong-tao Wang, Jing-Quan Wang, 2022, Frontiers in Pharmacology.

Targeting the ubiquitin-proteasome pathway to overcome anti-cancer drug resistance.

Y. Assaraf, Zhe-Sheng Chen, C. Ashby, 2019, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.

Benzoyl indoles with metabolic stability as reversal agents for ABCG2-mediated multidrug resistance.

Zhe-Sheng Chen, Cai-Ping Tan, Jing-Quan Wang, 2019, European journal of medicinal chemistry.

Selonsertib (GS-4997), an ASK1 inhibitor, antagonizes multidrug resistance in ABCB1- and ABCG2-overexpressing cancer cells.

S. Ambudkar, Zhe-Sheng Chen, Dexin Kong, 2019, Cancer letters.

Ulixertinib (BVD‐523) antagonizes ABCB1‐ and ABCG2‐mediated chemotherapeutic drug resistance

Zhe-Sheng Chen, Dong-Hua Yang, Dexin Kong, 2018, Biochemical pharmacology.

Glesatinib, a c-MET/SMO Dual Inhibitor, Antagonizes P-glycoprotein Mediated Multidrug Resistance in Cancer Cells

S. Ambudkar, Zhe-Sheng Chen, Dong-Hua Yang, 2019, Front. Oncol..

Tepotinib reverses ABCB1-mediated multidrug resistance in cancer cells.

Zhe-Sheng Chen, Zhuoxun Wu, Jing-Quan Wang, 2019, Biochemical pharmacology.

Establishment and Characterization of a Topotecan Resistant Non-small Cell Lung Cancer NCI-H460/TPT10 Cell Line

Zhe-Sheng Chen, Dong-Hua Yang, J. Wurpel, 2020, Frontiers in Cell and Developmental Biology.

Cycloruthenated Self‐Assembly with Metabolic Inhibition to Efficiently Overcome Multidrug Resistance in Cancers

Zhe-Sheng Chen, J. Li, Xinxing Liao, 2021, Advanced materials.

Chk1 Inhibitor MK-8776 Restores the Sensitivity of Chemotherapeutics in P-glycoprotein Overexpressing Cancer Cells

Zhe-Sheng Chen, Dong-Hua Yang, N. Ji, 2019, International journal of molecular sciences.

Modulating the function of ABCB1: in vitro and in vivo characterization of sitravatinib, a tyrosine kinase inhibitor

Zhe-Sheng Chen, Zhuoxun Wu, Jing-Quan Wang, 2020, Cancer communications.